Postpartum Acquired Hemophilia A in Two Women With Previously Undiagnosed Carrier Status for von Willebrand Disease Type 2N and Heterozygous p.R854Q Mutation

Documenti analoghi

• Emicizumab plasma levels after accelerated saturation in acquired haemophilia A
  di: Tristan Kloeter, et al.
  Pubblicazione: (2024)
• Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab
  di: Christian Pfrepper, et al.
  Pubblicazione: (2024)
• Development of Awareness Materials to Promote Early Diagnosis of Undiagnosed von Willebrand Disease: Integration of Multidisciplinary Perspectives Based on a Literature Review
  di: Azusa Nagao, et al.
  Pubblicazione: (2025)
• Acquired von Willebrand Syndrome in Metabolic Dysfunction–Associated Steatohepatitis With Altered VWF Kinetics and a Type 2‐Like Multimer Pattern
  di: Hiroaki Akiyama, et al.
  Pubblicazione: (2026)
• Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B
  di: Silvia Linari, et al.
  Pubblicazione: (2025)